IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -54.3% | 1,226,400 | -29.2% | 0.01% | -44.4% |
| Q2 2023 | $12,198 | +6.4% | 1,732,700 | -7.6% | 0.02% | +20.0% |
| Q1 2023 | $11,459 | -44.0% | 1,875,500 | -41.4% | 0.02% | -46.4% |
| Q4 2022 | $20,454 | -99.7% | 3,200,900 | +295.9% | 0.03% | +154.5% |
| Q3 2022 | $7,746,000 | +50.3% | 808,600 | +199.5% | 0.01% | +83.3% |
| Q4 2021 | $5,154,000 | +15.8% | 270,000 | +92.0% | 0.01% | 0.0% |
| Q1 2021 | $4,451,000 | +298.5% | 140,600 | +129.0% | 0.01% | +500.0% |
| Q3 2019 | $1,117,000 | – | 61,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |